The relationship between oligomeric state and protein function

Advances in Experimental Medicine and Biology

Volumn 747, Issue , 2012, Pages 74-90

  Griffin, Michael D W ^a   Gerrard, Juliet A ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; ENDONUCLEASE; INSULIN; LAMBDA CRO; OLIGOMER; TRIOSEPHOSPHATE ISOMERASE; TYROSINE TRANSFER RNA LIGASE; UNCLASSIFIED DRUG; AMINO ACID; PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; HUMAN; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; NONHUMAN; OLIGOMERIZATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; RESIDUE ANALYSIS; SERRATIA MARCESCENS; THERMOSTABILITY; TREND STUDY; WILD TYPE; ANIMAL; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; PROTEIN ENGINEERING; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN SUBUNIT; REVIEW; STRUCTURE ACTIVITY RELATION;

AMINO ACIDS; ANIMALS; BACTERIA; EVOLUTION, MOLECULAR; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTEIN SUBUNITS; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84866784002     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3229-6_5     Document Type: Article

References (88)

1. Eisenstein E, Schachman HK. Determining the roles of subunits in protein function. In: Creighton TE, ed. Protein Function. Oxford: IRL Press, 1989.
2. Perham RN. Self-assembly of biological macromolecules. Philos Trans R Soc Lond B Biol Sci 1975; 272(915):123-136.
3. Marianayagam NJ, Sunde M, Matthews JM. The power of two: protein dimerization in biology. Trends Biochem Sci 2004; 29(11):618-625.
4. Ali MH, Imperiali B. Protein oligomerization: How and why. Bioorg Med Chem 2005; 13(17):5013-5020.
5. Klotz IM, Darnall DW, Langerman NR. Quaternary structure of proteins. In: Hill RL, ed. The proteins. New York: Academic Press, 1975.
6. Beernink PT, Tolan DR. Disruption of the aldolase A tetramer into catalytically active monomers. Proc Natl Acad Sci USA 1996; 93(11):5374-5379.
7. Traut TW. Dissociation of enzyme oligomers: a mechanism for allosteric regulation. Crit Rev Biochem Mol Biol 1994; 29(2):125-163.
8. Monod J, Wyman J, Changeux JP. On the nature of allosteric transitions: a plausible model. J Mol Biol 1965:128-118.
9. Nooren IM, Thornton JM. Diversity of protein-protein interactions. EMBO J 2003; 22(14):3486-3492.
10. Goodsell DS, Olson AJ. Structural symmetry and protein function. Annu Rev Biophys Biomol Struct 2000:2905-153.
11. Ponstingl H, Thomas KB, Gorse D et al. Morphological aspects of oligorneric protein structures. Prog Biophys Mol Biol 2005; 89(1):9-35.
12. Papoian GA, Ulander J, Wolynes PG. Role of water mediated interactions in protein-protein recognition landscapes. J Am Chem Soc 2003; 125(30):9170-9178.
13. Ma B, Elkayam T, Wolfson H et al. Protein-protein interactions: structurally conserved residues distinguish between binding sites and exposed protein surfaces. Proc Natl Acad Sci, USA 2003; 100(10):5772-5777.
14. Ofran Y, Rost B. Analysing six types of protein-protein interfaces. J Mol Biol 2003; 325(2):377-387.
15. Jones S, Thornton JM. Principles of protein-protein interactions. Proc Natl Acad Sci, USA 1996; 93(1):13-20.
16. Jones S, Thornton JM. Analysis of protein-protein interaction sites using surface patches. J Mol Biol 1997; 272(1):121-132.
17. Jones S, Thornton JM. Protein-protein interactions: a review of protein dimer structures. Prog Biophys Mol Biol 1995; 63(1):31-65.
18. Lo Conte L, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol 1999; 285(5):2177-2198.
19. Nooren IM, Thornton JM. Structural characterisation and functional significance of transient protein-protein interactions. J Mol Biol 2003; 325(5):991-1018.
20. Jones S, Thornton JM. Prediction of protein-protein interaction sites using patch analysis. J Mol Biol 1997; 272(1):133-143.
21. Salwinski L, Eisenberg D. Computational methods of analysis of protein-protein interactions. Curr Opin Struct Biol 2003; 13(3):377-382.
22. Ofran Y, Rost B. Predicted protein-protein interaction sites from local sequence information. FEBS Lett 2003; 544(1-3):236-239.
23. B rooijmans N, Sharp KA, Kuntz ID. Stability of macromolecular complexes. Proteins 2002; 48(4):645-653.
24. Perutz MF. Science is not a quiet life: Unravelling the atomic mechanism of haemoglobin. Singapore: Imperial College Press, 1997.
25. P erugini MA, Griffin MDW, Smith BJ et al. Insight into the self-association of key enzymes from pathogenic species. Eur Biophys J 2005; 34(5):469-476.
26. Kim SY, Kim YW, Hegerl R et al. Novel type of enzyme multimerization enhances substrate affinity of oat beta-glucosidase. J Struct Biol 2005; 150(1):1-10.
27. Franke I, Meiss G, Blecher D et al. Genetic engineering, production and characterisation of monomeric variants of the dimeric Serratia marcescens endonuclease. FEBS Lett 1998; 425(3):517-522.
28. Mossing MC, Sauer RT. Stable, monomeric variants of - Cro obtained by insertion of a designed -hairpin sequence. Science 1990; 250(4988):1712-1715.
29. Borchert TV, Abagyan R, Jaenicke R et al. Design, creation and characterization of a stable, monomeric triosephosphate isomerase. Proc Natl Acad Sci, USA 1994; 91(4):1515-1518.
30. Jackson RM, Gelpi JL, Cortes A et al. Construction of a stable dimer of Bacillus stearothermophilus lactate dehydrogenase. Biochemistry 1992; 31(35):8307-8314.
31. Dobson CM. Getting out of shape. Nature 2002; 418(6899):729-730.
32. N ielsen L, Khurana R, Coats A et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 2001; 40(20):6036-6046.
33. Lashuel HA, Lai Z, Kelly JW. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M and L55P amyloid fibril formation. Biochemistry 1998; 37(51):17851-17864.
34. Foss TR, Kelker MS, Wiseman RL et al. Kinetic stabilization of the native state by protein engineering: Implications for inhibition of transthyretin amyloidogenesis. J Mol Biol 2005; 347(4):841-854.
35. Thorn DC, Meehan S, Sunde M et al. Amyloid fibril formation by bovine milk kappa-casein and its inhibition by the molecular chaperones alpha(s-) and beta-casein. Biochemistry 2005; 44(51):17027-17036.
36. S ouillac PO, Uversky VN, Fink AL. Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN. Biochemistry 2003; 42(26):8094-8104.
37. Raghu P, Reddy GB, Sivakumar B. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization. Arch Biochem Biophys 2002; 400(1):43-47.
38. Jenne DE, Denzel K, Blatzinger P et al. A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis. Proc Natl Acad Sci USA 1996; 93(13):6302-6307.
39. Hammarstrom P, Sekijima Y, White JT et al. D18G transthyretin is monomeric, aggregation prone and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Biochemistry 2003; 42(22):6656-6663.
40. Clegg JS. Properties and metabolism of the aqueous cytoplasm and its boundaries. Am J Physiol 1984; 246(2 Pt 2):R133-151.
41. Makhatadze GI, Loladze VV, Ermolenko DN et al. Contribution of surface salt bridges to protein stability: guidelines for protein engineering. J Mol Biol 2003; 327(5):1135-1148.
42. Karshikoff A, Ladenstein R. Ion pairs and the thermotolerance of proteins from hyperthermophiles: a "traffic rule" for hot roads. Trends Biochem Sci 2001; 26(9):550-556.
43. Yip KS, Britton KL, Stillman TJ et al. Insights into the molecular basis of thermal stability from the analysis of ion-pair networks in the glutamate dehydrogenase family. Eur J Biochem 1998; 255(2):336-346.
44. Gerk LP, Leven O, Muller-Hill B. Strengthening the dimerisation interface of Lac repressor increases its thermostability by 40C. J Mol Biol 2000; 299(3):805-812.
45. Vetriani C, Maeder DL, Tolliday N et al. Protein thermostability above 100C: a key role for ionic interactions. Proc Natl Acad Sci USA 1998; 95(21):12300-12305.
46. Lebbink JH, Knapp S, van der Oost J et al. Engineering activity and stability of Thermotoga maritima glutamate dehydrogenase. II: construction of a 16-residue ion-pair network at the subunit interface. J Mol Biol 1999; 289(2):357-369.
47. Kou H, Pugh BF. Engineering dimer-stabilizing mutations in the TATA-binding protein. J Biol Chem 2004; 279(20):20966-20973.
48. Ahern TJ, Casal JI, Petsko GA et al. Control of oligomeric enzyme thermostability by protein engineering. Proc Natl Acad Sci USA 1987; 84(3):675-679.
49. Casal JI, Ahern TJ, Davenport RC et al. Subunit interface of triosephosphate isomerase: site-directed mutagenesis and characterization of the altered enzyme. Biochemistry 1987; 26(5):1258-1264.
50. Jones DH, McMillan AJ, Fersht AR et al. Reversible dissociation of dimeric tyrosyl-tRNA synthetase by mutagenesis at the subunit interface. Biochemistry 1985; 24(21):5852-5857.
51. Ward WH, Jones DH, Fersht AR. Protein engineering of homodimeric tyrosyl-tRNA synthetase to produce active heterodimers. J Biol Chem 1986; 261(21):9576-9578.
52. Ward WH, Jones DH, Fersht AR. Effects of engineering complementary charged residues into the hydrophobic subunit interface of tyrosyl-tRNA synthetase. Appendix: Kinetic analysis of dimeric enzymes that reversibly dissociate into inactive subunits. Biochemistry 1987; 26(13):4131-4138.
53. Carter P, Bedouelle H, Winter G. Construction of heterodimer tyrosyl-tRNA synthetase shows tRNATyr interacts with both subunits. Proc Natl Acad Sci USA 1986; 83(5):1189-1192.
54. Vora JP, Owens DR, Dolben J et al. Recombinant DNA derived monomeric insulin analogue: Comparison with soluble human insulin in normal subjects. Bmj 1988; 297(6658):1236-1239.
55. Brange J, Ribel U, Hansen JF et al. Monomeric insulins obtained by protein engineering and their medical implications. Nature 1988; 333(6174):679-682.
56. H offman A, Ziv E. Pharmacokinetic considerations of new insulin formulations and routes of administration. Clin Pharmacokinet 1997; 33(4):285-301.
57. DeFelippis MR, Chance RE, Frank BH. Insulin self-association and the relationship to pharmacokinetics and pharmacodynamics. Crit Rev Ther Drug Carrier Syst 2001; 18(2):201-264.
58. Miller MD, Krause KL. Identification of the Serratia endonuclease dimer: structural basis and implications for catalysis. Protein Sci 1996; 5(1):24-33.
59. Franke I, Meiss G, Pingoud A. On the advantage of being a dimer, a case study using the dimeric Serratia nuclease and the monomeric nuclease from Anabaena sp. strain PCC 7120. J Biol Chem 1999; 274(2):825-832.
60. LeFevre KR, Cordes MHJ. Retroevolution of lambda Cro toward a stable monomer. Proc Natl Acad Sci USA 2003; 100(5):2345-2350.
61. Borchert TV, Pratt K, Zeelen JP et al. Overexpression of trypanosomal triosephosphate isomerase in Escherichia coli and characterisation of a dimer-interface mutant. Eur J Biochem 1993; 211(3):703-710.
62. Borchert TV, Zeelen JP, Schliebs W et al. An interface point-mutation variant of triosephosphate isomerase is compactly folded and monomeric at low protein concentrations. FEBS Lett 1995; 367(3):315-318.
63. Borchert TV, Abagyan R, Kishan KVR et al. The crystal structure of an engineered monomeric triosephosphate isomerase, monoTIM: the correct modeling of an 8-residue loop. Structure 1993; 1(3):205-213.
64. Olivares-Illana V, Perez-Montfort R, Lopez-Calahorra F et al. Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor. Biochemistry 2006; 45(8):2556-2560.
65. Berg T. Modulation of protein-protein interactions with small organic molecules. Angew Chem-Int Edit 2003; 42(22):2462-2481.
66. Ryan DP, Matthews JM. Protein-protein interactions in human disease. Curr Opin Struct Biol 2005; 15(4):441-446.
67. Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream. Nat Rev Drug Discov 2004; 3(4):301-317.
68. Schliebs W, Thanki N, Jaenicke R et al. A double mutation at the tip of the dimer interface loop of triosephosphate isomerase generates active monomers with reduced stability. Biochemistry 1997; 36(32):9655-9662.
69. Borchert TV, Kishan KV, Zeelen JP et al. Three new crystal structures of point mutation variants of monoTIM: conformational flexibility of loop-1, loop-4 and loop-8. Structure 1995; 3(7):669-679.
70. Mainfroid V, Terpstra P, Beauregard M et al. Three hTIM mutants that provide new insights on why TIM is a dimer. J Mol Biol 1996; 257(2):441-456.
71. Mainfroid V, Mande SC, Hol WG et al. Stabilization of human triosephosphate isomerase by improvement of the stability of individual -helices in dimeric as well as monomeric forms of the protein. Biochemistry 1996; 35(13):4110-4117.
72. McKenzie AN, Ely B, Sanderson CJ. Mutated interleukin-5 monomers are biologically inactive. Mol Immunol 1991; 28(1-2):155-158.
73. Dickason RR, Huston DP. Creation of a biologically active interleukin-5 monomer. Nature 1996; 379(6566):652-655.
74. Sano T, Vajda S, Smith CL et al. Engineering subunit association of multisubunit proteins: a dimeric streptavidin. Proc Natl Acad Sci USA 1997; 94(12):6153-6158.
75. Pazy Y, Eisenberg-Domovich Y, Laitinen OH et al. Dimer-tetramer transition between solution and crystalline states of streptavidin and avidin mutants. J Bacteriol 2003; 185(14):4050-4056.
76. Laitinen OH, Nordlund HR, Hytonen VP et al. Rational design of an active avidin monomer. J Biol Chem 2003; 278(6):4010-4014.
77. Velichko IS, Mikalahti K, Kasho VN et al. Trimeric inorganic pyrophosphatase of Escherichia coli obtained by directed mutagenesis. Biochemistry 1998; 37(2):734-740.
78. Salminen A, Efimova IS, Parfenyev AN et al. Reciprocal effects of substitutions at the subunit interfaces in hexameric pyrophosphatase of Escherichia coli. Dimeric and monomeric forms of the enzyme. J Biol Chem 1999; 274(48):33898-33904.
79. Fritsche P, Alves J. A monomeric mutant of restriction endonuclease EcoR I nicks DNA without sequence specificity. Biol Chem 2004; 385(10):975-985.
80. Zaremba M, Sasnauskas G, Urbanke C et al. Conversion of the tetrameric restriction endonuclease Bse634I into a dimer: Oligomeric structure-stability- function correlations. J Mol Biol 2005; 348(2):459-478.
81. Banci L, Benedetto M, Bertini I et al. Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme? Biochemistry 1998; 37(34):11780-11791.
82. Banci L, Bertini I, Chiu CY et al. Synthesis and characterization of a monomeric mutant Cu/Zn superoxide dismutase with partially reconstituted enzymic activity. Eur J Biochem 1995; 234(3):855-860.
83. Porvari KS, Herrala AM, Kurkela RM et al. Site-directed mutagenesis of prostatic acid phosphatase. Catalytically important aspartic acid 258, substrate specificity and oligomerization. J Biol Chem 1994; 269(36):22642-22646.
84. Breiter DR, Resnik E, Banaszak LJ. Engineering the quaternary structure of an enzyme: construction and analysis of a monomeric form of malate dehydrogenase from Escherichia coli. Protein Sci 1994; 3(11):2023-2032.
85. Beernink PT, Tolan DR. Subunit interface mutants of rabbit muscle aldolase form active dimers. Protein Sci 1994; 3(9):1383-1391.
86. Beernink PT, Tolan DR. Disruption of the aldolase A tetramer into catalytically active monomers. Proc Natl Acad Sci USA 1996; 93(11):5374-5379.
87. Bailey DL, Fraser ME, Bridger WA et al. A dimeric form of Escherichia coli succinyl-CoA synthetase produced by site-directed mutagenesis. J Mol Biol 1999; 285(4):1655-1666.
88. Griffin MDW, Dobson RCJ, Pearce FG et al. Evolution of quaternary structure in a homotetrameric enzyme. J Mol Biol 2008; 380(4): 691-703.